Radioprotective potential of histamine on rat small intestine and uterus

Submitted: 14 May 2012
Accepted: 8 September 2012
Published: 18 December 2012
Abstract Views: 889
PDF: 551
HTML: 901
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


The aim of this study was to improve knowledge about histamine radioprotective potential investigating its effect on reducing ionising radiation-induced injury and genotoxic damage on the rat small intestine and uterus. Forty 10-week-old male and 40 female Sprague-Dawley rats were divided into 4 groups. Histamine and histamine-5Gy groups received a daily subcutaneous histamine injection (0.1 mg/kg) starting 24 h before irradiation. Histamine-5Gy and untreated-5Gy groups were irradiated with a dose of whole-body Cesium-137 irradiation. Three days after irradiation animals were sacrificed and tissues were removed, fixed, and stained with haematoxylin and eosin, and histological characteristics were evaluated. Proliferation, apoptosis and oxidative DNA markers were studied by immunohistochemistry, while micronucleus assay was performed to evaluate chromosomal damage. Histamine treatment reduced radiation-induced mucosal atrophy, oedema and vascular damage produced by ionising radiation, increasing the number of crypts per circumference (239±12 vs 160±10; P<0.01). This effect was associated with a reduction of radiation-induced intestinal crypts apoptosis. Additionally, histamine decreased the frequency of micronuclei formation and also significantly attenuated 8-OHdG immunoreactivity, a marker of DNA oxidative damage. Furthermore, radiation induced flattening of the endometrial surface, depletion of deep glands and reduced mitosis, effects that were completely blocked by histamine treatment. The expression of a proliferation marker in uterine luminal and glandular cells was markedly stimulated in histamine treated and irradiated rats. The obtained evidences indicate that histamine is a potential candidate as a safe radioprotective agent that might increase the therapeutic index of radiotherapy for intra-abdominal and pelvic cancers. However, its efficacy needs to be carefully investigated in prospective clinical trials.



PlumX Metrics


Download data is not yet available.


Supporting Agencies

this work has been supported by grants from the University of Buenos Aires, 20020090300039, 20020100100270, Fundación Alberto J. Roemmers, the National Agency of Scientific and Technological Promotion BID PICT-2007-01022, CONICET (PIP 11220110101121), and

How to Cite

Carabajal, E., Massari, N., Croci, M., Martinel Lamas, D. J., Prestifilippo, J. P., Bergoc, R. M., Rivera, E. S., & Medina, V. A. (2012). Radioprotective potential of histamine on rat small intestine and uterus. European Journal of Histochemistry, 56(4), e48.